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Randomized controlled trial of a web-based
computer-tailored smoking cessation program as a 


































To assess the efficacy of  World Wide Web-based tailored behavioral












A total of  3971 subjects who purchased a particular brand of










Twenty-eight-day continuous abstinence rates were assessed





Using three approaches to the analyses of  6- and 12-week outcomes,
participants in the tailored condition reported clinically and statistically sig-
nificantly higher continuous abstinence rates than participants in the non-
tailored condition. In our primary analyses using as a denominator all subjects
who logged-on to the treatment site at least once, continuous abstinence rates
at 6 weeks were 29.0% in the tailored condition versus 23.9% in the non-












 0.0006); at 12 weeks continuous abstinence













over, satisfaction with the program was significantly higher in the tailored than




The results of  this study demonstrate a benefit of  the web-based
tailored behavioral support materials used in conjunction with nicotine
replacement therapy. A web-based program that collects relevant information
from users and tailors the intervention to their specific needs had significant










Smoking is the greatest preventable cause of  morbidity
and mortality in the developed world (World Health
Organization 2002)7. Because of  the lag between smok-
ing onset and disease occurrence, only cessation of  smok-
ing by current adult smokers is likely to yield reductions





Ideally, smoking cessation programs should have the
potential of  reaching a large number of  smokers, be easy
to adopt, be effective, have good fidelity (preserve the pro-
gram’s original effectiveness during the implementation
 

















1992). Most current antismoking efforts have been
unable to offer all of  these characteristics. Mass media
approaches have wide reach but low effectiveness (Lich-
tenstein & Glasgow 1992). On the other hand, intensive
multi-session clinical interventions can achieve up to















Computer-based communication technologies hold
the promise of  combining the benefits of  high-reach
media-based interventions, individually orientated clin-
ics and popular self-help programs. With the rapid devel-
opment of  such technology, tailoring a cessation program
to the specific needs and interests of  the smoker has
become increasingly more sophisticated and less expen-
sive (de Vries & Brug 1999; Strecher 1999). Tailoring
requires an assessment of  a person’s individual charac-
teristics, as opposed to targeting, which is based on
broader group identification (e.g. gender) (Kreuter, Stre-
cher & Glassman 1999; Strecher 1999). Tailoring is typ-
ically undertaken using computer programs that attempt
to use rules for problems ordinarily requiring an expert. A
commonly used program consists of: (a) an assessment of
individual characteristics relevant to smoking cessation,
(b) algorithms that use these data to generate interven-
tions tailored to the specific needs of  the user and (c) a
feedback protocol that delivers these messages to the
smoker in a clear, vivid form.
A generally positive body of  evidence demonstrates
the efficacy of  print-based computer-tailored smoking
cessation interventions in adults (Strecher 1999; Lan-
caster & Stead 2002), and two trials have found higher
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. 2000, 2001). A
key question is whether the effects of  tailoring can be
transferred to an even less costly, potentially high-reach
channel, the World Wide Web. To our knowledge there
are no published, randomized controlled trials of  web-
based smoking cessation programs (Lancaster & Stead







Subjects for the study were recruited from smokers in the
United Kingdom and Republic of  Ireland who purchased
NiQuitin CQ 21 mg patch and connected to a website to
enroll for free behavioral support materials. Eligible
enrollees were required to meet the following criteria: (1)
had a target quit date that was within 7 days from the
enrollment date; (2) provided a valid e-mail address and
had internet access for the duration of  the study; (3) were
attempting to quit smoking cigarettes (i.e. not smokeless
tobacco); (4) had been smoking more than 10 cigarettes
per day; (5) had purchased NiQuitin CQ 21 mg (21 mg of
nicotine, indicated for those who smoke at least 10 ciga-
rettes per day); (6) agreed to be contacted for follow-up e-
mail and web-based questionnaires at 6 and 12 weeks;
and (7) were 18 years of  age or older. Eligible enrollees
were invited to participate in the study; among those
invited, 76.8% agreed to participate.
A total of  3971 subjects completed the baseline ques-
tionnaire and were randomized to one of  two treatment
conditions. Within 24 hours of  completing the baseline
questionnaire, all subjects were notified by e-mail that
they had access to their behavioral support internet site.
The majority of  subjects were women (56.5%); the aver-
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large majority of  subjects (88.4%) smoked their first cig-




Enrollees were assigned randomly to one of  two web-
based treatment conditions: the active CQ PLAN or non-
tailored web-based smoking cessation materials. Partici-
pants were not informed of  their treatment assignment.
There were no significant differences in demographic or
smoking history characteristics between subjects ran-






 Stop Smoking Plan
(CQ PLAN)
 
Information collected in the enrollment questionnaire
was used to tailor the CQ PLAN materials (HealthMedia,
Inc., Ann Arbor, MI, USA), including: demographics,
smoking history, motives for quitting, expected difficulties
quitting and situations that were expected to present
challenges. In addition, subjects were allowed to identify
a supportive person that would receive an e-mail message
with tailored advice for supporting the subject. Program
materials consisted of  an initial web-based cessation
guide, three sequential tailored newsletters delivered via
the web and behavioral support messages delivered via e-
mail over a 10-week period. The content of  the program
was based on cognitive–behavioral methods of  smoking
cessation and relapse prevention, including stimulus
control, self-efficacy enhancement, suggestions for cop-
ing and encouraging compliance with nicotine replace-
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 different substantive combina-
tions (i.e. combinations excluding numeric and name-
based variables in the calculation) of  the materials could
be created. This represents a substantial increase over
previous tailored cessation programs in tailoring depth or
‘granularity’ of  the cessation advice provided. The format
and volume of  materials was equivalent for all CQ PLAN
enrollees, but content and presentation was tailored




Web-based materials of  the control condition had a
graphic design and navigational structure very similar to
the CQ PLAN. Cognitive–behavioral concepts similar to
those addressed in the CQ PLAN were presented. Instruc-
tion on product use was also similar to instructions
included in the CQ Plan. The primary differences were
that subjects in the control condition did not receive: (a)
tailored materials, i.e. enrollment data were not used to
select the information or organize the information
received by the user; (b) the three follow-up newsletters;
and (c) the opportunity to identify a supportive person





In the 6-week questionnaire, continuous abstinence was
defined as self-report of  no smoking at all for the previous
28 days. This is similar to generally accepted criteria used
by numerous regulatory agencies around the world for
assessing efficacy (US Food & Drug Administration
1995). There was, however, no biochemical verification
of  self-reported abstinence; biochemical verification is










12 weeks, continuous abstinence was defined as at least




Primary analyses focused on subjects who were random-
ized to one of  the two treatment conditions and logged-on
to the intervention website at least once (LO). Outcomes
were also examined using an intent-to-treat (ITT) analy-
sis (all subjects who were randomized to treatment
conditions regardless of  whether they logged-on to the
intervention website) and an analysis including subjects
who used the program and responded to the follow-up
questionnaire (UPR). In the LO and ITT analyses, subjects
who withdrew from the study or did not answer the absti-
nence questions were considered as treatment failures
(that they did smoke). Subjects were included in the UPR
population if  they: (1) did not withdraw from the study;
(2) answered the continuous abstinence question; (3)
reported having read at least some of  the materials; and
(4) did not report having used other smoking cessation
aids or programs.
Differences between treatment outcomes were as-
sessed using logistic regression. A secondary multivariate
model included age and baseline smoking rate as covari-
ates. We also assessed whether enhanced compliance
with nicotine replacement therapy (NRT) medication
could have mediated the treatment effects. In other





 se have a direct effect on cessation and/or did
the CQ PLAN have an indirect effect by increasing medi-





. (2000) found that the print-
based CQ PLAN intervention enhanced nicotine gum
compliance but also demonstrated that cessation out-
comes were not completely mediated by improved gum
compliance.
Satisfaction, helpfulness and relevance with the two
web-based treatments at the 6-week follow-up were also
ascertained. Subjects were asked whether they would rec-
ommend the program to other smokers and, if  they were
smoking at the 6-week follow-up, whether they would




Six weeks after their stated quit date, subjects were sent
an e-mail to access a questionnaire which asked about
their smoking abstinence, compliance with their pro-
gram and patches and perceptions regarding their
program. After a 2-week window, subjects were not per-
mitted to respond but could still continue in the study. At
12 weeks after their stated quit date, subjects were sent a
second questionnaire similar to the previous one, again
with a 2-week window.
Multiple e-mail reminders and compensation were
provided to encourage completion of  the follow-up ques-
tionnaires. Subjects completing either 6- or 12-week
questionnaires received oral care products to the value of
£5 (roughly $9) (e.g. toothpaste, brushes). Subjects com-
pleting both 6- and 12-week questionnaires received oral
care products to the value of  £20 (roughly $35). Ques-
tions about abstinence were administered through an ini-
tial e-mail message instructing the subject to click one of
two buttons—one button for ‘did not smoke’ or the other
for ‘did smoke’ during the previous 28 days (6-week
follow-up) or 10 weeks (12-week follow-up). When the
subject clicked a button that response was automatically
registered, and the subject brought to the website to com-
plete the remainder of  the questionnaire. Subjects who
clicked ‘did smoke’ were then asked if  they smoked during
 












the previous 7 days (point prevalence). All respondents





Of  the 3971 subjects enrolled in the study (constituting
the ITT denominator), 1991 were randomized to the CQ
PLAN and 1980 to the control condition. Of  those ran-
domized, 232 in the CQ PLAN and 238 in the control
condition never logged-on to the website to receive their
behavioral treatment. In the ITT analyses, subjects who
never logged-on to the website were included in the
denominator and considered to be smokers.
Of  the 3501 who logged on to the website at least
once, 31 subjects actively withdrew (15 in the CQ PLAN
and 16 in the control condition) before the 6-week
follow-up, leaving 3470 to receive the 6-week follow-up
web-based survey. A total of  1850 (53.3%) responded to
the 6-week follow-up survey. Among the respondents, 37
subjects reported not having read the materials; and 552
reported using other smoking cessation aids or programs
during the course of  the study. These subjects were
included in LO and ITT analyses but removed for the UPR
analyses, which examined those who responded to
follow-up, used the materials, and did not use other ces-
sation treatments.
Between 6- and 12-week follow-up periods, 15 more
subjects had withdrawn actively from the study (eight in
the CQ PLAN and seven in the control condition), leaving
3455 subjects, of  whom 1491 (43.2%) responded to the
12-week survey. A total of  45 subjects reported not hav-
ing read the materials and 471 reported using other
smoking cessation aids or programs. As in the 6-week
analysis procedure, these subjects were included in LO
and ITT analyses but removed for the UPR analyses.
Response rates to the 6- and 12-week follow-ups did
not differ between the two treatment conditions. Respon-
dents did not differ from non-respondents by age or gen-
der, but differed slightly in baseline smoking rate. On
average, 6-week non-respondents smoked 0.8 cigarettes
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Table 1 presents 6- and 12-week outcomes by treatment
condition. The primary 6-week LO analysis found a sig-
nificantly higher 28-day continuous abstinence rate
among subjects assigned to the CQ PLAN (29.0%) than
the control condition (23.9%). Among the ITT subjects
who enrolled in the study but did not necessarily log-on
to the website to receive treatment, a significantly higher
6-week 28-day continuous abstinence rate was also
found among CQ PLAN subjects (25.6%) than control
subjects (21.0%). Significant differences between the CQ
PLAN and control conditions remained at 12-week fol-
low-up using both LO (22.8% versus 18.1%) and ITT
(20.1% versus 15.9%) analyses. UPR analyses also dem-
onstrate consistently higher continuous abstinence rates
in the CQ PLAN than the control condition at 6 weeks
(54.4% versus 46.8%) and 12 weeks (55.4% versus
43.3%). These outcomes did not change when baseline
age and smoking rate were entered into the logistic
model.
Subjects in the CQ PLAN group reported using nico-
tine patches for significantly longer over the course of  the








 0.001) Given that patch
use typically stops when smokers relapse, this could be
simply because those in the CQ PLAN group were more
likely to remain abstinent. However, it is noteworthy that
the effect of  the CQ PLAN remained largely unaffected


































OR 95% CI of  ORs P-valuen % n %
 
Logged-on (LO)
28-day abstinence at 6 weeks 1759 29.0 1742 23.9 1.30 1.12–1.51 0.0006
10-week abstinence at 12 weeks 1759 22.8 1742 18.1 1.34 1.13–1.58 0.0006
All randomized (ITT)
28-day abstinence at 6 weeks 1991 25.6 1980 21.0 1.29 1.12–1.50 0.0006
10-week abstinence at 12 weeks 1991 20.1 1980 15.9 1.33 1.13–1.57 0.0005
Used program and responded (UPR)
28-day abstinence at 6 weeks 640 54.4 588 46.8 1.36 1.08–1.70 0.008
10-week abstinence at 12 weeks 446 55.4 418 43.3 1.63 1.24–2.13 0.0004
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On the 6-week questionnaire, respondents in the CQ
PLAN condition were more likely than those in the con-
trol condition to report the materials as being helpful and
relevant (Table 2), and more likely to state they would
recommend the program to others. Among those who
were smoking at the 6-week follow-up, CQ PLAN respon-
dents were more likely to state that they would use the




This study demonstrated the efficacy of  the tailored web-
based CQ PLAN behavioral smoking cessation program
over a non-tailored web-based program in subjects using
nicotine patches. Using three different analysis strategies,
differing in whether subjects logged-on to the web site,
used the program materials, did not use other cessation
treatments or responded to follow-up, subjects random-
ized to the CQ PLAN condition reported significantly
higher rates of  cessation at both 6- and 12-week follow-
up. Moreover, the effects on cessation from the tailored
CQ PLAN were above and beyond any effects related to
nicotine patch use.
The effect sizes of  this intervention are comparable to
those found in print-based tailored materials studies. In a
meta-analysis of  print-based tailored versus non-tailored
self-help smoking cessation materials (Lancaster & Stead
2002) found an average odds ratio of  1.36 (CI: 1.13–
1.64) for computer-tailored materials compared with
non-tailored or stage-matched materials (10 studies). As




. (1996) found an
average odds ratio of  1.34 (CI: 1.19–1.51) for telephone
counseling compared with control conditions (13
studies).
The effects found in this study are also consistent with
the results of  two trials of  print-based computer-tailored
behavioral materials added to nicotine replacement ther-




. 2000), provision of  the
tailored print Committed Quitters program with nicotine
gum therapy significantly increased quit rates compared
to the use of  nicotine gum with prepackaged instructions
and cessation advice alone (6 weeks: 36.2 versus 24.7%;
12 weeks: 27.6 versus 17.7%). In a similar study of  the





. 2001), abstinence rates differed
among those who reported using their assigned materials
(over 80% of  the sample – 6 weeks: 38.2 versus 30.7%;
12 weeks: 18.2 versus 11.1%).
While the efficacy of  these three approaches appears
comparable, the costs differ substantially. The costs of
commercial telecounseling products usually range
between $150 and $250 per smoker; tailored print prod-
ucts usually vary between $5 and $40 per smoker and
tailored web products, depending on size of  the popula-
tion, can be less than $1 per smoker. Thus the web may
offer a relatively high-reach, high-efficacy, low-cost
approach to population-based smoking cessation.
Web-based programs may also have the potential for





The number of  adult web users in the world now exceeds
half  a billion (NUA Internet Survey 2003). Over 60% of
individuals in the United Kingdom (NUA Internet Survey
2003) and over 70% of  individuals in the United States
(UCLA Internet Report 2003) use the internet. The Pew
Internet and American Life Project survey conducted in
late 2002 (Fox & Fallows 2003) found roughly 7 million
individuals (6% of  US internet users) searching the web
for information on how to quit smoking. This reach
appears to compare favorably with an estimated
500 000–700 000 (1.1–1.7%) of  adult smokers calling a
quitline over the course of  a year (Ossip-Klein & McIntosh
2003).
The effects of  the CQ PLAN intervention in the study
were incremental to the well-known effects of  nicotine





One objective of  the program was to enhance compliance
with use of  the nicotine patch, and smokers in the CQ
PLAN were indeed found to use patches for longer.
Whether this was because of  compliance interventions in
the CQ PLAN or just because they were abstinent longer
is not known. In any case, the analysis showed that the























































































*Question only asked of  subjects still smoking at follow-up.
 












increased patch use, but derived from the advice and sup-
port conveyed by the material.
The current study should not be considered a direct
test isolating the effects of  tailoring on the efficacy of
smoking cessation materials. The CQ PLAN had more
waves of  interaction with the user than the non-tailored
control condition and it is possible that the additional
interactions may have created the effect on smoking ces-
sation. However, a direct test of  the effect of  increasing
mailings of  tailored materials failed to demonstrate effects




. 1999). The CQ PLAN—but not
the control condition—also allowed the subject to identify
a supportive person who would subsequently receive an e-
mail message with tailored advice for supporting the sub-
ject. While this addition may have accounted for improve-
ments in cessation, a review of  research studying the
impact of  buddy systems (May & West 2000) found only
two of  10 such studies to demonstrate a significant effect
on cessation. None the less, a control condition that
allows an adequate test of  tailoring per se would require
far greater structural similarities to the tailored condition.
This study could not verify claims of  abstinence bio-
chemically because of  the geographical spread of  the
sample. However, false reporting is considered to be min-









. 1992). The high rate of
loss to follow-up is also a limitation. However, the loss to
follow-up was similar to that typically found in large-
scale smoking cessation trials. In our ITT analysis all sub-
jects lost to follow-up were considered to be smokers, pos-
sibly making the ITT success rates unduly low. There are
many possible reasons for loss to follow-up (e.g. lost
access to e-mail or internet; blockage of  e-mail reminders
due to so-called ‘spam detectors’). Regardless, the
observed difference between the treatment conditions
could not be explained by dropout, as there was no differ-
ence in dropout rates and a significant treatment effect
was observed.
Another limitation of  the study is the relatively short
follow-up period. Relapse curves from smoking cessation
trials indicate that it is possible to extrapolate from
10 weeks of  continuous abstinence to long-term success
with relapse rates being the same in intervention and




. 2003). Thus, the odds
ratio indicating the relative efficacy of  the CQ PLAN and
control interventions should be generalizable, although
the absolute abstinence rates would be expected to dimin-
ish over time. Future web-based studies should examine
longer-term abstinence rates.
To our knowledge, this is the first large-scale trial of  an
automated web-based smoking cessation intervention.
Results of  this study demonstrate a promising short-term
outcome of  tailored web-based programming in conjunc-
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